Latest Articles

Publication Date
Estate agent who was diagnosed with endometriosis wins £31k - MSN

Estate agent who was diagnosed with endometriosis wins £31k MSN

Published: Jan. 21, 2025, 3:51 a.m.
The high cost of neglecting women’s health - asianews.network

The high cost of neglecting women’s health asianews.network

Published: Jan. 21, 2025, 2:27 a.m.
Endometriosis and risk of cardiovascular disease: a systematic review and meta-analysis - BMC Public Health

Endometriosis and risk of cardiovascular disease: a systematic review and meta-analysis BMC Public Health

Published: Jan. 21, 2025, 1:41 a.m.
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - ABN Newswire

Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR ABN Newswire

Published: Jan. 21, 2025, 12:38 a.m.
Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer - OncLive

Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer OncLive

Published: Jan. 20, 2025, 9:34 p.m.
5 actions to boost women's health and the global economy - World Economic Forum

5 actions to boost women's health and the global economy World Economic Forum

Published: Jan. 20, 2025, 8:05 p.m.
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer - Cancer Network

Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer Cancer Network

Published: Jan. 20, 2025, 5:08 p.m.
Endometriosis: A Chronic Disease - MSN

Endometriosis: A Chronic Disease MSN

Published: Jan. 20, 2025, 3:22 p.m.
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider

Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Jan. 20, 2025, 10:56 a.m.
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment - beQuoted

Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment beQuoted

Published: Jan. 20, 2025, 8:21 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!